Physician

Chandan D S Cheema, MD

According to 2025 Medicare claims, Chandan Cheema, MD (NPI: 1053488114) practices internal medicine in the Sacramento-Roseville-Folsom, CA market, with the plurality of this provider's patient population coming from Sacramento, CA. This provider's primary affiliated billing organization is JRS MEDICAL CONSULTING, INC. (NPI: 1912300278; TIN: 471804386) and primary practice location at 95841-4107.

Cheema's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 196 traditional Medicare patients, billed 242,994 HCPCS/CPT codes, and received $3,595,968 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 7,621 prescription claims across 611 beneficiaries totaling $611,001 in drug costs, led by Eliquis (Apixaban). DME data shows 218 claims. Open Payments data shows 2 records totaling $52. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $2,280 to $3,595,968. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $736,421 and ending at $611,001. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $197 to $21,476.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	33	38	$2,280
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	684	1,076	$104,692
2019	259	280	$25,622
2020	62	66	$5,021
2021	93	27,685	$547,624
2022	964	100,028	$1,924,947
2023	487	132,521	$2,468,943
2024	196	242,994	$3,595,968

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	753	15,681	$736,421
2016	273	5,549	$235,160
2017	131	2,607	$96,955
2018	393	5,486	$285,741
2019	455	9,727	$566,274
2020	133	1,721	$111,390
2021	52	525	$23,645
2022	582	7,734	$533,054
2023	763	15,513	$1,142,378
2024	611	7,621	$611,001

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	22	26	$424
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	89	379	$63,744
2019	13	257	$12,117
2020	N/R	72	$562
2021	N/R	N/R	N/R
2022	61	153	$21,798
2023	81	604	$20,510
2024	26	218	$6,599

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
96413	Administration of chemotherapy into vein, 1 hour or less	77	507	$112
96401	Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle	61	157	$62
96365	Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	81	195	$50
J0897	Injection, denosumab, 1 mg	49	4,860	$20
J7050	Infusion, normal saline solution, 250 cc	49	80	$0

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	263	4,263	$87,176
Austedo	Deutetrabenazine	17	238	$46,447
Xifaxan	Rifaximin	25	277	$32,189
Jardiance	Empagliflozin	33	687	$14,109
Vraylar	Cariprazine Hcl	18	252	$12,996

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	48	$3,018
K0001	Standard wheelchair	Y	26	110	$1,328
E0260	Hospital bed, semi-electric (head and foot adjustment), with any type side rails, with mattress	Y	N/R	27	$1,160
E1392	Portable oxygen concentrator, rental	Y	N/R	33	$1,093

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$52	Lilly USA, LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Chandan D. S. Cheema, MD?

Tedicare shows public-source Medicare data for Chandan D. S. Cheema, MD (NPI 1053488114), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Chandan D. S. Cheema, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Chandan D. S. Cheema, MD?

Chandan D. S. Cheema, MD is linked to JRS MEDICAL CONSULTING, INC. (billing NPI 1912300278) in the available physician profile data.

Does Chandan D. S. Cheema, MD have Open Payments data?

Chandan D. S. Cheema, MD has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.